Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Falskov, Britt ^a   Hermann, Thomas S ^a   Raunsø, Jakob ^a   Christiansen, Buris ^a   Rask Madsen, Christian ^b   Major Pedersen, Atheline ^a   Køber, Lars ^c   Torp Pedersen, Christian ^a   Dominguez, Helena ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b JOSLIN DIABETES CENTER   (United States)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Beta blocker; Endothelial function; Heart failure

Indexed keywords

CARVEDILOL; INSULIN; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; SEROTONIN; CARBAZOLE DERIVATIVE; METOPROLOL; PROPANOLAMINE DERIVATIVE;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; HEART FAILURE; HEART RATE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG SUBSTITUTION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGED; AGED, 80 AND OVER; CARBAZOLES; DRUG SUBSTITUTION; ENDOTHELIUM, VASCULAR; FEMALE; HEART FAILURE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; PROPANOLAMINES; VASODILATION;

EID: 80053972869     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-91     Document Type: Article

References (19)

1. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003, 362(9377):7-13. 10.1016/S0140-6736(03)13800-7, 12853193.
2. Erbs S, Gielen S, Linke A, Mobius-Winkler S, Adams V, Baither Y, Schuler G, Hambrecht R. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J 2003, 146(2):280-5. 10.1016/S0002-8703(03)00184-4, 12891196.
3. Meyer B, Mortl D, Strecker K, Hulsmann M, Kulemann V, Neunteufl T, Pacher R, Berger R. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005, 46(6):1011-8. 10.1016/j.jacc.2005.04.060, 16168284.
4. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005, 111(3):310-4. 10.1161/01.CIR.0000153349.77489.CF, 15655134.
5. Paolisso G, De Riu S, Marrazzo G, Verza M, Varricchio M, D'Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 1991, 40(9):972-7. 10.1016/0026-0495(91)90075-8, 1895963.
6. Swan JW, Anker SD, Walton C, Godsland IF, Clark LA, Leyva F, Stevenson JC, Coats AJ. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997, 30(2):527-32. 10.1016/S0735-1097(97)00185-X, 9247528.
7. Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT, Oakes R, Lukas MA, Anderson KM, Bell DS. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. Jama 2004, 292(18):2227-36. 10.1001/jama.292.18.2227, 15536109.
8. Torp-Pedersen C, Metra M, Charlesworth A, Spark P, Lukas MA, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Remme WJ, Scherhag A. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). Heart 2007, 93(8):968-73. 10.1136/hrt.2006.092379, 1994413, 17237130.
9. Kveiborg B, Hermann TS, Major-Pedersen A, Christiansen B, Rask-Madsen C, Raunso J, Kober L, Torp-Pedersen C, Dominguez H. Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes-a randomized study. Cardiovasc Diabetol 9:21.
10. Sanderson JE, Leung LY, Chan SK, Yip GW, Fung JW, Yu CM. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?. Eur J Heart Fail 2005, 7(5):874-7. 10.1016/j.ejheart.2005.03.002, 16043407.
11. Rask-Madsen C, Ihlemann N, Krarup T, Christiansen E, Kober L, Nervil Kistorp C, Torp-Pedersen C. Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001, 50(11):2611-8. 10.2337/diabetes.50.11.2611, 11679442.
12. Joannides R, Bellien J, Thuillez C. Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries. Fundam Clin Pharmacol 2006, 20(3):311-20. 10.1111/j.1472-8206.2006.00406.x, 16671967.
13. Matsuda Y, Akita H, Terashima M, Shiga N, Kanazawa K, Yokoyama M. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. Am Heart J 2000, 140(5):753-9. 10.1067/mhj.2000.110093, 11054621.
14. Nishioka K, Nakagawa K, Umemura T, Jitsuiki D, Ueda K, Goto C, Chayama K, Yoshizumi M, Higashi Y. Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy. Heart 2007, 93(2):247-8. 1861396, 17228074.
15. Ciccone MM, Iacoviello M, Puzzovivo A, Scicchitano P, Monitillo F, De Crescenzo F, Caragnano V, Sassara M, Quistelli G, Guida P, Favale S. Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol 100(6):515-21.
16. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305(24):2556-64.
17. Schafer A, Fraccarollo D, Tas P, Schmidt I, Ertl G, Bauersachs J. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism. Eur J Heart Fail 2004, 6(2):151-9. 10.1016/j.ejheart.2003.10.009, 14984722.
18. Kostis JB, Sanders M. The association of heart failure with insulin resistance and the development of type 2 diabetes. Am J Hypertens 2005, 18(5 Pt 1):731-7.
19. Kukin ML, Mannino MM, Freudenberger RS, Kalman J, Buchholz-Varley C, Ocampo O. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure. J Am Coll Cardiol 2000, 35(1):45-50. 10.1016/S0735-1097(99)00504-5, 10636257.